NHSX backs 14 digital health projects after funding roundNHSX, the government agency tasked with digitally transforming NHS England, has granted funding to 14 projects in its Share XNHSX backs 14 digital health projects after funding roundhttps://pharmaphorum.com/news/nhsx-backs-14-digital-health-projects-after-funding-round/
UK pledges £5.4bn to NHS to ease COVID-19 treatment backlogNHS England will get an extra £5.4 billion ($7.5 billion) in funding over the next six months to Share XUK pledges £5.4bn to NHS to ease COVID-19 treatment backloghttps://pharmaphorum.com/news/uk-pledges-5-4bn-to-nhs-to-ease-covid-19-treatment-backlog/
White House pledges $3 billion war chest for COVID antiviralsThe Biden Administration has said it will allocate $3 billion of its pandemic rescue plan to the development Share XWhite House pledges $3 billion war chest for COVID antiviralshttps://pharmaphorum.com/news/white-house-pledges-3-billion-war-chest-for-covid-antivirals/
Novo Holding launches latest call for antibiotic investment proposalsWith the focus on COVID-19 over the last year it’s easy to forget another deadly pandemic caused by Share XNovo Holding launches latest call for antibiotic investment proposalshttps://pharmaphorum.com/news/novo-holding-launches-latest-call-for-antibiotic-investment-proposals/
Minervax raises €47.4m in Series B funding round for GBS shotDenmark’s MinervaX has raised €47.4 million (around $56 million) in a Series B funding round to take its Share XMinervax raises €47.4m in Series B funding round for GBS shothttps://pharmaphorum.com/news/minervax-raises-e47-4m-in-series-b-funding-round-for-gbs-shot/
Sinovac raises $515m to boost production of potential COVID-19 vaccineChina’s Sinovac has raised $515 million to increase its distribution and production capacity as clinical development of its Share XSinovac raises $515m to boost production of potential COVID-19 vaccinehttps://pharmaphorum.com/news/sinovac-raises-515m-to-boost-production-of-potential-covid-19-vaccine/
Swiss start-up Noema raises $59m to develop neurology drugs offloaded by RocheSwiss biotech Noema has raised 54 million Swiss francs ($59m) to develop four neurological disorder drugs licensed in Share XSwiss start-up Noema raises $59m to develop neurology drugs offloaded by Rochehttps://pharmaphorum.com/news/swiss-start-up-noema-raises-59m-to-develop-neurology-drugs-offloaded-by-roche/
Sidekick Health raises $20m to fund digital therapeutics expansionGamified digital therapeutics firm Sidekick Health has raised $20 million in a Series A funding round, which it Share XSidekick Health raises $20m to fund digital therapeutics expansionhttps://pharmaphorum.com/news/sidekick-health-raises-20m-to-fund-digital-therapeutics-expansion/
SparingVision raises €44.5m for retinitis pigmentosa gene therapyFrench biotech SparingVision has raised 44.5 million euros ($52.7 million) to develop its gene therapy for a rare Share XSparingVision raises €44.5m for retinitis pigmentosa gene therapyhttps://pharmaphorum.com/news/sparingvision-raises-44-5-million-euros-for-retinitis-pigmentosa-gene-therapy/
